A Targeted Next-Generation Sequencing Assay Detects a High Frequency of Therapeutically Targetable Alterations in Primary and Metastatic Breast Cancers: Implications for Clinical Practice

BACKGROUND. The aim of this study was to assess the frequency of potentially actionable genomic alterations in breast cancer that could be targeted with approved agents or investigational drugs in clinical trials using a next-generation sequencing-based genomic profiling assay performed in a Clinica...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vasan, Neil, Yelensky, Roman, Wang, Kai, Moulder, Stacy, Dzimitrowicz, Hannah, Avritscher, Rony, Wang, Baliang, Wu, Yun, Cronin, Maureen T., Palmer, Gary, Symmans, W. Fraser, Miller, Vincent A., Stephens, Philip, Pusztai, Lajos
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2014
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4012963/
https://ncbi.nlm.nih.gov/pubmed/24710307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0377
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados